Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by stockbuphoonon Jul 28, 2021 11:38am
60 Views
Post# 33616781

Voucher cash will not move this up

Voucher cash will not move this up

As it's been known since June 4th. It's one year of cash and they have not identified any milestones except preclinical studies which again will not move the needle. It's been 2 months since they cancelled 2 phase 2 4050/ fez trials as their primary milestones and still crickets on liver, kidney and heart. "Penicillin", as they called it, seems to be a well kept secret for Thomvest only

Maybe your production jobs are going to create that double or triple? LOL

<< Previous
Bullboard Posts
Next >>